00:25 , Jun 21, 2017 |  BC Extra  |  Company News

Management tracks

Biogen Inc. (NASDAQ:BIIB) named Ginger Gregory EVP and chief human resources officer, effective July 17. She was chief human resources officer at Shire plc (LSE:SHP; NASDAQ:SHPG). Neurodegenerative, inflammation and cancer company Active Biotech AB (SSE:ACTI)...
22:15 , Jan 6, 2017 |  BioCentury  |  Finance

Good riddance

  Investors aren’t lamenting the end of 2016, but they are pinned between anxiety and optimism for the year ahead. The anxiety stems from uncertainty about U.S. government policies for healthcare under the new administration....
07:00 , Sep 26, 2016 |  BC Week In Review  |  Financial News

Aytu proposes follow-on

Aytu BioScience Inc. (OTCQX:AYTU), Englewood, Colo.   Business: Genitourinary   Date announced: 2016-09-21   Type: Follow-on   To be raised: Up to $14.4 million   Shares: TBD   Price prior: $3.50   Underwriters: Joseph Gunnar;...
07:00 , Aug 1, 2016 |  BC Week In Review  |  Financial News

Aytu completes private placement

Aytu BioScience Inc. (OTCQX:AYTU), Englewood, Colo.   Business: Genitourinary   Date completed: 2016-07-28   Type: Private placement   Raised: $500,000   Shares: 133,690   Shares after offering: 3.9 million   Investor: Lincoln Park Capital Fund...
07:00 , Jul 11, 2016 |  BioCentury  |  Finance

Ground up

Steve Edelson, Senior Editor   As the third quarter gets under way, biotech is shaking off the hangover of the Brexit vote while facing the overhang of the November election in the U.S. Fifteen bankers...
07:00 , May 9, 2016 |  BC Week In Review  |  Company News

Acerus Pharmaceuticals, Aytu deal

Acerus (formerly Trimel Pharmaceuticals Corp. ) granted Aytu exclusive, U.S. marketing rights to testosterone replacement therapy Natesto testosterone nasal gel, effective June 30. Acerus will receive an $8 million upfront payment and is eligible for...
07:00 , May 9, 2016 |  BC Week In Review  |  Financial News

Aytu completes follow-on

Aytu BioScience Inc. (OTCQX:AYTU), Englewood, Colo.   Business: Genitourinary   Date completed: 2016-05-02   Type: Follow-on   Raised: $7.5 million   Shares: 18.8 million   Price: $0.40   Shares after offering: 44.9 million   Underwriters:...
07:00 , May 2, 2016 |  BC Week In Review  |  Financial News

Aytu amends follow-on

Aytu BioScience Inc. (OTCQX:AYTU), Englewood, Colo.   Business: Genitourinary   Date announced: 2016-04-25   Type: Follow-on   To be raised: TBD   Shares: TBD   Price prior: $0.69   Underwriters: Joseph Gunnar; Fordham Financial Management...
07:00 , May 2, 2016 |  BC Week In Review  |  Financial News

Acerus Pharmaceuticals completes private placement

Acerus Pharmaceuticals Corp. (TSX:ASP), Mississauga, Ontario   Business: Drug delivery, Endocrine/Metabolic, Inflammation   Date completed: 2016-04-27   Type: Private placement   Raised: C$2.5 million ($2 million)   Shares: 12.2 million   Price: C$0.21   Shares...
07:00 , Apr 11, 2016 |  BC Week In Review  |  Company News

Aytu, Allegis deal

Aytu granted Allegis exclusive rights to co-promote Primsol trimethoprim in the U.S. Allegis will promote the drug to pediatricians; Aytu retains all other rights. Primsol, a liquid formulation of antibiotic trimethoprim, is approved in the...